Mechanisms of Epstein-Barr virus-associated autoimmunity: a comparative overview

Area of Science:

• Immunology
• Virology
• Autoimmunity

Background:

• Epstein-Barr virus (EBV) is linked to autoimmune diseases including multiple sclerosis (MS), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA).
• EBV's role in autoimmunity involves shared and disease-specific immunopathogenic mechanisms.
• Key shared pathways include immune dysfunction, molecular mimicry, autoreactive B-cell infection, and type 1 interferon (IFN-1) response dysfunction.

Purpose of the Study:

• To elucidate the multifaceted roles of Epstein-Barr virus (EBV) in the pathogenesis of various autoimmune diseases.
• To detail disease-specific mechanisms by which EBV contributes to MS, SLE, and RA.
• To explore how host genetic factors, such as HLA alleles, modulate EBV's impact on autoimmune disease susceptibility and progression.

Main Methods:

• Review and synthesis of existing literature on EBV and autoimmune disease pathogenesis.
• Analysis of shared and distinct immunological mechanisms across different autoimmune conditions.
• Examination of the influence of host genetics and environmental factors on EBV-associated autoimmunity.

Main Results:

• EBV utilizes shared mechanisms like molecular mimicry and immune cell dysfunction, alongside disease-specific pathways in MS, SLE, and RA.
• Specific examples include EBV-associated CD8+ T-cell responses in MS CNS, IFN-driven inflammation in SLE, and synovial lymphoid structures in RA.
• Host genetics, particularly HLA variations, significantly influence antigen presentation and immune responses to EBV, modulating disease risk.

Conclusions:

• EBV acts as a context-dependent immunological modifier rather than a uniform trigger for autoimmune diseases.
• The pathogenic effects of EBV are shaped by infection timing, tissue environment, host genetics, and co-exposures.
• Understanding these complex interactions is crucial for developing targeted preventive and therapeutic strategies for EBV-associated autoimmune diseases.